Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without
Summary: Cell entry of the pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mediated by its spike protein S. As a main antigenic determinant, S protein is in focus of various therapeutic strategies. Besides particle-cell fusion, S mediates fusion between infected and uninfect...
Main Authors: | Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004221001383 |
Similar Items
-
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
by: Yue Zheng, et al.
Published: (2021-01-01) -
A Fusion Peptide in the Spike Protein of MERS Coronavirus
by: Entedar A. J. Alsaadi, et al.
Published: (2019-09-01) -
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
by: Katharine H.D. Crawford, et al.
Published: (2020-05-01) -
Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.
by: Min Zhao, et al.
Published: (2021-06-01) -
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
by: Xiaoyi Fan, et al.
Published: (2020-07-01)